By Ruchika Sharma
Hyderabad: Aurobindo Pharma Limited has announced the merger of its two wholly owned step-down subsidiaries – Pharmacin B.V. and Agile Pharma B.V. Both the companies are incorporated in the Netherlands. Effective July 1, 2025, Pharmacin B.V. has been merged with its holding company, Agile Pharma B.V., to enhance the substantive character of Agile with business activity and also saving regulatory and compliance expenses. For the financial year ending March 31, 2025, Pharmacin B.V. posted a turnover of Rs 197.9 million, while Agile Pharma B.V. reported a turnover of Rs 66.4 million. Both companies are involved in the manufacturing and marketing of pharmaceutical products.In June, Aurobindo incorporated a new wholly owned subsidiary in the United States through its arm Aurobindo Pharma USA Inc. The newly formed entity, CRESEDEMO PHARMA LLC, was incorporated on June 13, 2025, with the aim of expanding the company鈥檚 pharmaceutical products business in the US market.Read also: Aurobindo Pharma arm incorporates new subsidiary in USEarlier, in May, Curateq Biologics Private Limited, another wholly owned subsidiary of the Company, incorporated a new wholly owned subsidiary in the Netherlands by the name of CuraTeQ Biologics B.V.Read also: Aurobindo Pharma arm Curateq Biologics incorporates new wholly owned subsidiary in NetherlandsAurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries. The company has 30 manufacturing and packaging facilities that are approved by regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. The Company鈥檚 product portfolio is spread over seven major therapeutic/product areas encompassing CNS, Anti-Retroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and AntiAllergic, supported by a strong R&D set-up.Read also: Aurobindo Pharma arm restarts production at Kakinada Penicillin-G plant after fire incident